The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective

被引:122
作者
Lucignani, G
Paganelli, G
Bombardieri, E
机构
[1] European Inst Oncol, Div Radiat Therapy, Unit Mol Imaging, I-20141 Milan, Italy
[2] Univ Milan, Inst Radiol Sci, I-20122 Milan, Italy
[3] European Inst Oncol, Div Nucl Med, Milan, Italy
[4] NCI, Div Nucl Med, Milan, Italy
[5] NCI, PET Ctr, Milan, Italy
关键词
positron emission tomography; quantification; oncology; standardized uptake value; SUV;
D O I
10.1097/01.mnm.0000134329.30912.49
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Among clinicians who use positron emission tomography (PET), the standardized uptake value (SUV) is a popular semi-quantitative value that can be easily assessed whenever a PET study is performed under physiological and pathological conditions. It provides an index of regional tracer uptake normalized to the administered dose of tracer. The simplicity of SUV assessment contrasts with the complexity of full quantitative procedures requiring blood sampling and possibly dynamic scanning, which limits patient throughput and significantly increases the workload of a PET centre. Two main clinical conditions/variables affect the significance and usefulness of the SUV: the type and stage of the disease being assessed. Diagnosis, prognosis and therapy monitoring represent the possible uses of SUV. In the above clinical conditions an SUV may provide information about the single lesion in which it is assessed, but the utility of such information depends largely on its integration with all the available clinical and instrumental data. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:651 / 656
页数:6
相关论文
共 31 条
[1]
GRADING LIPOSARCOMAS WITH PET USING [F-18] FDG [J].
ADLER, LP ;
BLAIR, HF ;
WILLIAMS, RP ;
PATHRIA, MN ;
MAKLEY, JT ;
JOYCE, MJ ;
ALKAISI, N ;
MIRALDI, F .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (06) :960-962
[2]
FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy [J].
Beggs, AD ;
Hain, SF ;
Curran, KM ;
O'Doherty, MJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (04) :542-546
[3]
Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy [J].
Conrad, GR ;
Sinha, P .
NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (11) :1129-1137
[4]
Cremerius U, 2001, NUKLEARMED-NUCL MED, V40, P23
[5]
Demura Y, 2003, J NUCL MED, V44, P540
[6]
[18F]fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer [J].
Dhital, K ;
Saunders, CAB ;
Seed, PT ;
O'Doherty, MJ ;
Dussek, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 18 (04) :425-428
[7]
Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer [J].
Greven, KM ;
Williams, DW ;
McGuirt, WF ;
Harkness, BA ;
D'Agostino, RB ;
Keyes, JW ;
Watson, NE .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (11) :942-946
[8]
FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy [J].
Hain, SF ;
Curran, KM ;
Beggs, AD ;
Fogelman, I ;
O'Doherty, MJ ;
Maisey, MN .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (09) :1336-1340
[9]
HAMBERG LM, 1994, J NUCL MED, V35, P1308
[10]
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET [J].
Hickeson, M ;
Yun, MJ ;
Matthies, A ;
Zhuang, HM ;
Adam, LE ;
Lacorte, L ;
Alavi, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (12) :1639-1647